A
Anders Karlén
Researcher at Uppsala University
Publications - 116
Citations - 4192
Anders Karlén is an academic researcher from Uppsala University. The author has contributed to research in topics: Protease & Angiotensin II. The author has an hindex of 33, co-authored 114 publications receiving 3525 citations.
Papers
More filters
Journal ArticleDOI
Correlation of human jejunal permeability (in vivo) of drugs with experimentally and theoretically derived parameters. A multivariate data analysis approach.
Susanne Winiwarter,Nicholas M. Bonham,Fredrik Ax,Anders Hallberg,Hans Lennernäs,Anders Karlén +5 more
TL;DR: The effective permeability (Peff) in the human jejunum (in vivo) of 22 structurally diverse compounds was correlated with both experimentally determined lipophilicity values and calculated molecular descriptors, and models that correlate passive intestinal permeability to physicochemical descriptors were derived.
Journal ArticleDOI
The global preclinical antibacterial pipeline.
TL;DR: The innovative potential of the preclinical pipeline compared with the clinical pipeline is encouraging but fragile and much more work, focus and funding are needed for the novel approaches to result in effective antibacterial therapies to sustainably combat antibacterial resistance.
Journal ArticleDOI
Towards the sustainable discovery and development of new antibiotics
Marcus Miethke,Marco Pieroni,Tilmann Weber,Mark Brönstrup,Peter Hammann,Ludovic Halby,Paola B. Arimondo,Philippe Glaser,Bertrand Aigle,Helge B. Bode,Helge B. Bode,Rui Moreira,Yanyan Li,Andriy Luzhetskyy,Marnix H. Medema,Jean-Luc Pernodet,Marc Stadler,José R. Tormo,Olga Genilloud,Andrew W. Truman,Kira J. Weissman,Eriko Takano,Stefano Sabatini,Evi Stegmann,Heike Brötz-Oesterhelt,Wolfgang Wohlleben,Myriam Seemann,Martin Empting,Anna K. H. Hirsch,Brigitta Loretz,Claus-Michael Lehr,Alexander Titz,Jennifer Herrmann,Timo Jaeger,Silke Alt,Thomas Hesterkamp,Mathias Winterhalter,Andrea Schiefer,Kenneth Pfarr,Achim Hoerauf,Heather Graz,Michael Graz,Mika Lindvall,Savithri Ramurthy,Anders Karlén,Maarten van Dongen,Hrvoje Petković,Andreas Keller,Frédéric Peyrane,Stefano Donadio,Laurent Fraisse,Laura J. V. Piddock,Ian H. Gilbert,Heinz E. Moser,Rolf Müller +54 more
TL;DR: In this paper, the authors present a strategic blueprint to substantially improve our ability to discover and develop new antibiotics, and propose both short-term and long-term solutions to overcome the most urgent limitations in the various sectors of research and funding.
Journal ArticleDOI
Relationships between structure and interaction kinetics for HIV-1 protease inhibitors.
Per-Olof Markgren,Wesley Schaal,Markku Hämäläinen,Anders Karlén,Anders Hallberg,Bertil Samuelsson,U. Helena Danielson +6 more
TL;DR: The interaction between HIV-1 protease and 58 structurally diverse transition-state analogue inhibitors has been analyzed by a surface plasmon resonance based biosensor and shows that different classes of inhibitors fall into distinct clusters in maps.
Journal ArticleDOI
Unexpected binding mode of a cyclic sulfamide HIV-1 protease inhibitor.
Kristina Bäckbro,Seved Löwgren,Katrin Österlund,Johnson Atepo,Torsten Unge,Johan Hultén,Nicholas M. Bonham,Wesley Schaal,Anders Karlén,Anders Hallberg +9 more
TL;DR: Two cyclic, C2-symmetric HIV-1 protease inhibitors, one sulfamide and one urea derivative, both comprising phenyl ether groups in the P1/P1' positions, were cocrystallized with HIV- 1 protease, and the crystal structures were determined to 2.0 A resolution.